Akhondzadeh Shahin, Abbasi Seyed Hesameddin
Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):113-8. doi: 10.1177/153331750602100211.
Alzheimer's disease (AD) is characterized by profound memory loss sufficient to interfere with social and occupational functioning. It is the most common form of dementia, affecting more than 20 million people worldwide. AD is characterized by an insidious loss of memory, associated functional decline, and behavioral disturbances. Patients may live for more than a decade after they are diagnosed with AD, making it the leading cause of disability in the elderly. The incidence of AD ranges from 1 to 4 percent of the population per year, rising from its lowest level at ages 65 to 70 years to rates that may approach 6 percent for those over the age of 85 years. The first neurotransmitter defect discovered in AD involved acetylcholine (ACh). As cholinergic function is required for short-term memory, the cholinergic deficit in AD was also believed to be responsible for much of the short-term memory deficit. Clinical drug trials in patients with AD have focused on drugs that augment levels of ACh in the brain to compensate for the loss of cholinergic function. These drugs have included ACh precursors, muscarinic agonists, nicotinic agonists, and acetylcholinesterase inhibitors. The most highly developed and successful approaches to date have employed acetylcholinestrase inhibition. Although some Food and Drug Administration-approved drugs are available for the treatment of Alzheimer's disease, the outcomes are often unsatisfactory, and there is a place for alternative medicine, in particular, herbal medicine. This paper reviews the clinical effects of a number of commonly used types of herbal medicines for the treatment of AD.
阿尔茨海默病(AD)的特征是严重的记忆丧失,严重到足以干扰社交和职业功能。它是最常见的痴呆形式,全球有超过2000万人受其影响。AD的特征是隐匿性记忆丧失、相关的功能衰退和行为障碍。患者在被诊断出患有AD后可能存活十多年,这使其成为老年人残疾的主要原因。AD的发病率每年在人口的1%至4%之间,从65至70岁时的最低水平上升到85岁以上人群可能接近6%的发病率。在AD中发现的第一个神经递质缺陷涉及乙酰胆碱(ACh)。由于短期记忆需要胆碱能功能,AD中的胆碱能缺陷也被认为是导致大部分短期记忆缺陷的原因。针对AD患者的临床药物试验集中在提高大脑中ACh水平以补偿胆碱能功能丧失的药物上。这些药物包括ACh前体、毒蕈碱激动剂、烟碱激动剂和乙酰胆碱酯酶抑制剂。迄今为止最成熟和成功的方法是使用乙酰胆碱酯酶抑制。尽管美国食品药品监督管理局批准了一些药物用于治疗阿尔茨海默病,但结果往往不尽人意,替代医学,尤其是草药医学仍有一席之地。本文综述了多种常用草药治疗AD的临床效果。